CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-In- Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Total Common Equity	Noncontrolling Interests in Subsidiaries
Balance at Oct. 31, 2021	$ 31,951	$ 71	$ 25,556	$ 12,963	$ (2,017)	$ 36,573	$ (4,622)
Balance (in Shares) at Oct. 31, 2021		7,036
Stock based compensation expense	5		5			5
Vested share units granted to Directors	61		61			61
Vested share units granted to Directors (in Shares)		2
Distributions to noncontrolling interests in subsidiaries	(19,700)						(19,700)
Net income (loss)	69,153			45,777		45,777	23,376
Dividends declared	(703)			(703)		(703)
Net unrealized loss on interest rate swap contracts	1,262				928	928	334
Balance at Jan. 31, 2022	82,029	$ 71	25,622	58,037	(1,089)	82,641	(612)
Balance (in Shares) at Jan. 31, 2022		7,038
Balance at Oct. 31, 2021	31,951	$ 71	25,556	12,963	(2,017)	36,573	(4,622)
Balance (in Shares) at Oct. 31, 2021		7,036
Net income (loss)	68,152
Balance at Apr. 30, 2022	82,727	$ 71	25,666	56,981	769	83,487	(760)
Balance (in Shares) at Apr. 30, 2022		7,040
Balance at Jan. 31, 2022	82,029	$ 71	25,622	58,037	(1,089)	82,641	(612)
Balance (in Shares) at Jan. 31, 2022		7,038
Stock based compensation expense	5		5			5
Vested share units granted to Directors	39		39			39
Vested share units granted to Directors (in Shares)		2
Distributions to noncontrolling interests in subsidiaries	(180)						(180)
Net income (loss)	(1,001)			(352)		(352)	(649)
Dividends declared	(704)			(704)		(704)
Net unrealized loss on interest rate swap contracts	2,539				1,858	1,858	681
Balance at Apr. 30, 2022	82,727	$ 71	25,666	56,981	769	83,487	(760)
Balance (in Shares) at Apr. 30, 2022		7,040
Balance at Oct. 31, 2022	24,739	$ 73	30,635	(6,208)	1,409	25,909	(1,170)
Balance (in Shares) at Oct. 31, 2022		7,321
Stock based compensation expense	5		5			5
Vested share units granted to Directors	26		26			26
Vested share units granted to Directors (in Shares)		2
Stock options exercised	1,226	$ 1	1,225			1,226
Stock options exercised (in Shares)		113
Distributions to noncontrolling interests in subsidiaries	(1,850)						(1,850)
Net income (loss)	46			419		419	(373)
Dividends declared	(541)			(541)		(541)
Net unrealized loss on interest rate swap contracts	(450)				(450)	(450)
Balance at Jan. 31, 2023	23,201	$ 74	31,891	(6,330)	959	26,594	(3,393)
Balance (in Shares) at Jan. 31, 2023		7,436
Balance at Oct. 31, 2022	24,739	$ 73	30,635	(6,208)	1,409	25,909	(1,170)
Balance (in Shares) at Oct. 31, 2022		7,321
Net income (loss)	(240)
Balance at Apr. 30, 2023	22,384	$ 74	32,043	(6,605)	852	26,364	(3,980)
Balance (in Shares) at Apr. 30, 2023		7,446
Balance at Jan. 31, 2023	23,201	$ 74	31,891	(6,330)	959	26,594	(3,393)
Balance (in Shares) at Jan. 31, 2023		7,436
Stock based compensation expense	5		5			5
Stock awards granted to Directors	140		140			140
Stock awards granted to Directors (in Shares)		9
Stock options exercised	7		7			7
Stock options exercised (in Shares)		1
Distributions to noncontrolling interests in subsidiaries	(204)						(204)
Net income (loss)	(286)			97		97	(383)
Dividends declared	(372)			(372)		(372)
Net unrealized loss on interest rate swap contracts	(107)				(107)	(107)
Balance at Apr. 30, 2023	$ 22,384	$ 74	$ 32,043	$ (6,605)	$ 852	$ 26,364	$ (3,980)
Balance (in Shares) at Apr. 30, 2023		7,446